Guillermo Montalban Bravo

  • 153 Citations
  • 6 h-Index
20132019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Myelodysplastic Syndromes Medicine & Life Sciences
decitabine Medicine & Life Sciences
Azacitidine Medicine & Life Sciences
Leukemia, Myelomonocytic, Chronic Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Mutation Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
Diploidy
Cytogenetics
Survival
13 Citations
Myelodysplastic Syndromes
Risk Management
Azacitidine
decitabine
Stem Cell Transplantation
6 Citations
Myelodysplastic Syndromes
4'-N-benzoylstaurosporine
Cytotoxins
Standard of Care
Clinical Trials
2 Citations

The role ofID Hmutations in acute myeloid leukemia

Montalban Bravo, G. & DiNardo, C., Apr 1 2018, In : Future Oncology. 14, 10, p. 979-993 15 p.

Research output: Contribution to journalReview article

Isocitrate Dehydrogenase
Acute Myeloid Leukemia
Mutation
Genetic Epigenesis
Therapeutics